the drug is also used off label in the treatment of anxiety disorders and panic disorder tiagabine is approved by u s food and drug administration fda as an adjunctive treatment for partial seizures in individuals of age 12 and up it may also be prescribed off label by physicians to treat anxiety disorders and panic disorder as well as neuropathic pain including fibromyalgia for anxiety and neuropathic pain tiagabine is used primarily to augment other treatments tiagabine may be used alongside selective serotonin reuptake inhibitors serotonin norepinephrine reuptake inhibitors or benzodiazepines for anxiety or antidepressants gabapentin other anticonvulsants or opioids for neuropathic pain the most common side effect of tiagabine is dizziness other side effects that have been observed with a rate of statistical significance relative to placebo include asthenia somnolence nervousness memory impairment tremor headache diarrhea and depression adverse effects such as confusion aphasia difficulty speaking clearly stuttering and paresthesia a tingling sensation in the body s extremities particularly the hands and fingers may occur at higher dosages of the drug e g over 8 mg day tiagabine may induce seizures in those without epilepsy particularly if they are taking another drug which lowers the seizure threshold there